Detalhe da pesquisa
1.
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study.
Ann Hematol
; 100(7): 1743-1753, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33774681
2.
Pomalidomide-Responsive Extramedullary Myeloma Relapsed after Allogeneic Hematopoietic Transplant and Refractory to Multiple Lines of Chemotherapy.
Chemotherapy
; 64(2): 110-114, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31533095
3.
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy Via STAT3.
Int J Mol Sci
; 20(14)2019 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32565533
4.
Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study.
Cancers (Basel)
; 15(16)2023 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37627065
5.
Low content of clonogenic progenitors on day+18 is associated with acute graft-versus-host disease and predicts transplant-related mortality.
Exp Hematol
; 95: 58-67.e4, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33444663
6.
Serum free light chains and multiple myeloma: Is it time to extend their application?
Clin Case Rep
; 8(4): 617-624, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32274022
7.
Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.
J Clin Med
; 8(10)2019 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31623097
8.
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network.
J Clin Med
; 8(6)2019 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31248142